Q1 2021 Jubilant Life Sciences Ltd Earnings Call Transcript
Good day and welcome to Jubilant Life Sciences Limited earnings conference call for the quarter ended June 30, 2020. (Operator instructions)
Please note that this conference is being recorded. I now hand the conference over to Mr. Hemant Bakhru, Head, Investor Relations. Thank you and over to you, sir.
Thank you. Good evening, everybody. I'm Hemant Bakhru, Head, Investor Relations at Jubilant Life Sciences. Thank you for being with us on our Q1 FY21 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Pramod Yadav, CEO, Jubilant Pharma; Mr. Rajesh Srivastava, CEO, Life Science Ingredients; and Mr. Alok Vaish, President and CEO, Jubilant Life Sciences Limited. I now invite Mr.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |